Search
Jazz Pharmaceuticals PLC
JAZZAdd to Watchlist
231.390USD
-4.650-1.97%
Close 10-06 16:00（ET）
14.54BMarket Cap
561.70P/E TTM
Jazz Pharmaceuticals PLC (JAZZ) Stock Price Target & Forecast
Analyst Rating
Based on 20 analysts giving stock ratings to Jazz Pharmaceuticals PLC in the past month.
Buy
5 Strong Buy
14 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
293.949USD+24.73%
JAZZ Analyst Recommendation Trends
In the current month, JAZZ has received 14 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. JAZZ average Analyst price target in the last month is 293.949.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
5
5
6
6
6
6
6
6
14
14
11
10
10
10
10
10
1
1
1
1
1
1
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
20
18
17
17
17
17
18
JAZZ Analyst Rating for Peer Comparison
Updated: Oct 6, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Eli Lilly and Co
LLY
10
18
3
1
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, JAZZ EPS is projected to reach 6.462 in FY2026Q3, following reported EPS of 3.051 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
6.52
4.57
6.18
6.46
6.51
Actual
3.33
4.74
3.05
--
--
Surprise
-48.87%
+3.70%
-50.60%
--
--
FAQs
What is Jazz Pharmaceuticals PLC's expected revenue for the next quarter?
Jazz Pharmaceuticals PLC's expected revenue is 1.21B.
What is Jazz Pharmaceuticals PLC's price target?
Analysts forecast that Jazz Pharmaceuticals PLC's price target is USD 293.95, with the highest forecast at USD 337.00 and the lowest forecast at USD 199.92.
How have Jazz Pharmaceuticals PLCJAZZ's recent earnings per share performed?
The market expectation was USD 3.05, while Jazz Pharmaceuticals PLCJAZZ's earnings per share (EPS) for the previous quarter was USD 4.74. EPS for the next quarter is expected at USD 6.46.
What is the analyst rating for Jazz Pharmaceuticals PLC?
Based on the ratings of Jazz Pharmaceuticals PLC's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.